Uterine Fibroid
Oncology·MeSH: Leiomyoma
Prevalence
1594.0 / 100K
Incidence
133.5 / 100K/yr
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 1(1)
| Drug | Company |
|---|---|
| xiaflex | BIOSPECIFICS TECHNOLOGIES CORP (BSTC) |
Compare drugs
Frequently asked questions
How many drugs are in development for Uterine Fibroid?
BioSniper tracks 3 drugs in development for Uterine Fibroid across 3 companies.
How many clinical trials target Uterine Fibroid?
There are 2 clinical trials targeting Uterine Fibroid tracked by BioSniper.
What is the prevalence of Uterine Fibroid?
The estimated prevalence of Uterine Fibroid is approximately 1594.0 per 100,000 population.
Deep-dive into Uterine Fibroid
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis